What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary scientific interests are in Surgery, Cancer, Internal medicine, Pathology and Esophageal cancer.
His Surgery research incorporates elements of Metastasis, Radiology and Sentinel node.
His Cancer research integrates issues from Phases of clinical research, Disease and Lymph node.
His biological study spans a wide range of topics, including Gastroenterology and Oncology.
Yuko Kitagawa combines subjects such as Epithelial–mesenchymal transition, Cancer research, Stem cell and Pancreatic cancer with his study of Pathology.
The Esophageal cancer study combines topics in areas such as Chemoradiotherapy, Incidence, Retrospective cohort study and General surgery.
His most cited work include:
- Mesenchymal stem cells: Mechanisms of immunomodulation and homing. (500 citations)
- Improvement in the Results of Surgical Treatment of Advanced Squamous Esophageal Carcinoma During 15 Consecutive Years (449 citations)
- International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG) (377 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Surgery, Cancer, Oncology and Esophageal cancer.
His research combines Gastroenterology and Internal medicine.
His research investigates the connection between Surgery and topics such as Sentinel node that intersect with issues in Early Gastric Cancer.
Yuko Kitagawa interconnects Cancer research and Lymph node, Pathology in the investigation of issues within Cancer.
His studies in Oncology integrate themes in fields like Colorectal cancer, Clinical trial and Cisplatin.
His studies deal with areas such as Esophagus, Chemoradiotherapy and Carcinoma as well as Esophageal cancer.
He most often published in these fields:
- Internal medicine (35.47%)
- Surgery (31.79%)
- Cancer (19.66%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (35.47%)
- Surgery (31.79%)
- Esophageal cancer (14.96%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Surgery, Esophageal cancer, Surgical oncology and Cancer are his primary areas of study.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
His research in Esophageal cancer intersects with topics in Esophagus and Cardiothoracic surgery.
His Surgical oncology research incorporates themes from Pathological, MEDLINE and General surgery.
His Cancer research is multidisciplinary, incorporating perspectives in Cancer research and Lymph node.
The concepts of his Lymph node study are interwoven with issues in Sentinel lymph node and Radiology.
Between 2018 and 2021, his most popular works were:
- Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial (141 citations)
- Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. (124 citations)
- Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 (101 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary scientific interests are in Internal medicine, Esophageal cancer, Cancer, Surgery and Esophagectomy.
He has researched Internal medicine in several fields, including Gastroenterology and Oncology.
His Esophageal cancer research includes themes of Esophagus, Phases of clinical research, Cardiothoracic surgery and Docetaxel.
His work deals with themes such as Surgical oncology and Cancer research, which intersect with Cancer.
His work in Surgery addresses subjects such as Pneumonia, which are connected to disciplines such as Perioperative.
His study in Esophagectomy is interdisciplinary in nature, drawing from both Chemoradiotherapy and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
